Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-12-15 Purchase |
2022-12-19 08:09 am |
Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO |
1,200 | $2.5476 | $3,057 | 2,441 (Indirect Direct) |
View |
2021-09-22 Purchase |
2021-09-23 4:10 pm |
Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO |
8,200 | $0.5851 | $4,798 | 384,507 (Indirect Direct) |
View |
2021-05-07 Purchase |
2021-05-10 4:12 pm |
Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO |
6,000 | $0.832 | $4,992 | 376,307 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-06-15 Option Award |
2022-06-17 4:10 pm |
N/A N/A |
Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO |
39,473 | $0 | 49,664 (Direct) |
View |
2021-12-22 Option Award |
2021-12-23 5:45 pm |
N/A 2031-01-20 |
Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO |
821,168 | $0 | 1,177,884 (Direct) |
View |
2021-12-15 Tax Withholding |
2021-12-23 5:45 pm |
N/A N/A |
Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO |
18,636 | $0.31 | 1,177,884 (Direct) |
View |
2021-12-05 Tax Withholding |
2021-12-14 6:27 pm |
N/A N/A |
Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO |
9,155 | $0.35 | 375,352 (Direct) |
View |
2021-04-20 Option Award(A) |
2021-05-17 4:04 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director |
38,012 | $0 | 38,012 (Direct) |
View |
2021-04-20 Option Award |
2021-04-22 5:57 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director |
64,935 | $0 | 314,586 (Direct) |
View |
2021-04-13 Option Award |
2021-04-15 9:07 pm |
N/A 2031-04-13 |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-01-20 Option Award |
2021-01-22 6:27 pm |
N/A N/A |
Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO |
65,435 | $0 | 370,307 (Direct) |
View |
2021-01-18 Tax Withholding |
2021-01-20 7:54 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director |
6,816 | $3.03 | 249,651 (Direct) |
View |
2021-01-18 Exercise |
2021-01-20 7:54 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director |
5,000 | $0 | 249,651 (Direct) |
View |
2021-01-02 Tax Withholding |
2021-01-05 5:04 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director |
5,599 | $3.09 | 251,467 (Direct) |
View |
2020-12-05 Tax Withholding |
2020-12-09 5:45 pm |
N/A N/A |
Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO |
83,015 | $1.14 | 304,872 (Direct) |
View |
2020-12-05 Tax Withholding |
2020-12-09 5:43 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE President and CEO |
34,128 | $2.3 | 257,066 (Direct) |
View |